diabetes

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February
Motley Fool
Sun, 03/12/17 - 10:51 am
MannKind
diabetes
inhaled insulin
Afrezza
Virta Health looks to reverse, not treat, Type II diabetes
Drug Delivery Business News
Wed, 03/8/17 - 05:36 pm
Virta Health
type 2 diabetes
diabetes
devices
patients
mobile apps
Merck aims to put Amazon's Alexa to work on voice-enabled diabetes tools
Fierce Pharma
Wed, 03/8/17 - 09:46 am
Merck
Amazon
Alexa
diabetes
devices
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition
Endpoints
Tue, 03/7/17 - 11:55 am
Merck
Pfizer
FDA
ertugliflozin
diabetes
type 2 diabetes
This Is Big News For Diabetics And Biotech Investors
Forbes
Wed, 03/1/17 - 10:23 am
diabetes
biotech
Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017
Market Realist
Tue, 02/28/17 - 11:52 pm
Merck
Januvia
diabetes
vaccines
Can MannKind Be Saved?
Barron's
Tue, 02/28/17 - 11:25 am
MannKind
Afrezza
diabetes
inhaled insulin
Where are all the new diabetes drugs?
Stat
Mon, 02/20/17 - 11:31 am
diabetes
innovation
drug development
Sanofi’s Unique Foothold in Diabetes and Cardiovascular
Market Realist
Mon, 02/20/17 - 09:54 am
Sanofi
diabetes
cardiovascular disease
Abbott touts association between monitoring and improved glucose control
Drug Delivery News
Wed, 02/15/17 - 11:14 am
Abbott Labs
devices
blood glucose monitoring
diabetes
FreeStyle Libre
Eli Lilly wins label expansion for Trulicity injection with basal insulin
Endpoints
Wed, 02/8/17 - 09:39 pm
Eli Lilly
Trulicity
basal insulin
diabetes
Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
Medical Marketing and Media
Wed, 02/8/17 - 09:24 pm
drug spending
diabetes
rheumatoid arthritis
oncology
FDA accepts Intarcia’s NDA for diabetes drug-device combo
Mass Device
Mon, 02/6/17 - 11:14 am
FDA
Intarcia
diabetes
devices
drug-device combos
Medici
MannKind Attempts to Revive Afrezza Sales
Investopedia
Fri, 02/3/17 - 11:21 am
MannKind
Afrezza
diabetes
inhaled insulin
Teva Confirms Generic Victoza® Patent Challenge in the United States
Yahoo
Thu, 02/2/17 - 09:20 am
Teva Pharmaceutical
patents
diabetes
Victoza
generics
Novo Nordisk
Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit
Yahoo/Reuters
Tue, 01/31/17 - 10:09 am
Sanofi
Novo Nordisk
Eli Lilly
price fixing
price collusion
diabetes
Afrezza Sales Still Low As MannKind Prepares For Investor Update
Seeking Alpha
Sat, 01/28/17 - 02:32 pm
Afrezza
MannKind
diabetes
inhaled insulin
Johnson & Johnson mulls ‘strategic options’ for diabetes business
Mass Device
Tue, 01/24/17 - 10:25 am
JNJ
diabetes
devices
LifeScan
Calibra
Animas
Sanofi’s Suliqua combination therapy approved in European Union
Mass Device
Wed, 01/18/17 - 03:50 pm
Sanofi
Suliqua
Europe
insulin
diabetes
devices

Pages